相关实验视频
Updated: May 1, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.4K
被膜密封剂poloxamer阻塞的变形性心力衰竭
Soichiro Yasuda1, DeWayne Townsend, Daniel E Michele
1Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan 48109-0622, USA.
Nature
|July 19, 2005
概括
在杜恩肌肉发育不良症 (DMD) 中缺乏素会导致心脏细胞受损. 膜密封剂Poloxamer 188可以纠正心脏细胞中的这些缺陷,并改善小鼠的心脏功能.
科学领域:
- 心血管生物学 心血管生物学
- 肌肉生理学 肌肉生理学
- 生物材料科学 生物材料科学
背景情况:
- 杜恩肌肉发育不良 (DMD) 是由于缺乏素而导致的肌肉逐渐恶化.
- 心肌病和心力衰竭是DMD患者死亡的主要原因.
- 在DMD中心肌病理生理学比骨肌更不了解,但可能存在不同的机制.
研究的目的:
- 为了研究隔离心脏肌细胞中脱素缺乏的功能后果.
- 评估Poloxamer 188作为DMD相关心肌病的膜密封剂的治疗潜力.
主要方法:
- 研究了孤立的缺素心肌细胞,以确定它们的遵守性和的处理性.
- 波洛克萨默188在体外应用,以评估其对肌细胞功能的影响.
- 在活体中接受波洛克萨默188的变质小鼠,以评估心脏功能和压力下的几何状况.
主要成果:
- 缺乏素的心脏肌细胞表现出降低了服从性和增加了对拉伸介导过载的敏感性,导致细胞死亡.
- 在体外Poloxamer 188治疗纠正了这些细胞缺陷.
- 在活体中,Poloxamer 188改善了心室几何形状,并在压力期间预防了缩性小鼠的急性心力衰竭.
结论:
- 双素缺乏直接影响心脏肌细胞机制和存活.
- 波洛克萨默188显示出作为缓解DMD相关心肌病的治疗剂的潜力.
- 膜密封剂为肌肉衰竭中心力衰竭提供了一种新的治疗策略,等待进一步的临床研究.
相关概念视频
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753

